Association of Rho/Rho-kinase gene polymorphisms and expressions with obesity-related metabolic syndrome

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 9, 2015, Pages 1680-1688

  Tabur, S ^a   Oztuzcu, S ^a   Oguz, E ^b   Korkmaz, H ^a   Eroglu, S ^a   Ozkaya, M ^a   Demiryurek A T ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Diabetes mellitus; Metabolic syndrome; Obesity; Rho proteins; Rhokinase

Indexed keywords

GENOMIC DNA; MESSENGER RNA; RHO KINASE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; REAL TIME POLYMERASE CHAIN REACTION; RHO GUANINE NUCLEOTIDE BINDING PROTEIN GENE; RHO KINASE GENE; TURK (PEOPLE); ABDOMINAL OBESITY; CASE CONTROL STUDY; COMPLICATION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; POLYMORPHISM, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RHO-ASSOCIATED KINASES;

EID: 84942279304     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. EXPERT PANEL ON DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD CHOLESTEROL IN ADULTS. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
2. GRUNDY SM, BREWER HB JR, CLEEMAN JI, SMITH SC JR, LENFANT C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Repor t of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
3. FERRANNINI E. Is insulin resistance the cause of the metabolic syndrome? Ann Med 2006; 38: 42-51.
4. FERRANNINI E, BALKAU B. Insulin: in search of a syndrome. Diabet Med 2002; 19: 724-729.
5. GRUNDY SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008; 28: 629-636.
6. YAZICI HU, POYRAZ F, TURFAN M, SEN N, TAVIL Y, TULMAC M, VATANKULU MA, AYGÜL N, OZDO RU I, ABACI A. The prevalence of the metabolic syndrome and its impact on the left ventricular systolic function in the patients with non-diabetic first ST elevation myocardial infarction. Eur Rev Med Pharmacol Sci 2012; 16: 90-95.
7. PRIETO D, CONTRERAS C, SÁNCHEZ A. Endothelial dysfunction, obesity and insulin resistance. Curr Vasc Pharmacol 2014; 12: 412-426.
8. BEGUM N, SANDU OA, ITO M, LOHMANN SM, SMOLENSKI A. Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 2002; 277: 6214-6222.
9. ZHOU Q, GENSCH C, LIAO JK. Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease. Trends Pharmacol Sci 2011; 32: 167-173.
10. FURUKAWA N, ONGUSAHA P, JAHNG WJ, ARAKI K, CHOI CS, KIM HJ, LEE YH, KAIBUCHI K, KAHN BB, MASUZAKI H, KIM JK, LEE SW, KIM YB. Role of Rho-kinase in regulation of insulin action and glucose homeostasis. Cell Metab 2005; 2: 119-129.
11. RIKITAKE Y, LIAO JK. Rho-kinase mediates hyperglycemia- induced plasminogen activator inhibitor- 1 expression in vascular endothelial cells. Circulation 2005; 111: 3261-3268.
12. LIU PY, CHEN JH, LIN LJ, LIAO JK. Increased Rho kinase activity in a Taiwanese population with metabolic syndrome. J Am Coll Cardiol 2007; 49: 1619-1624.
13. NAIK JS, XIANG L, HESTER RL. Enhanced role for RhoA-associated kinase in adrenergic-mediated vasoconstriction in gracilis arteries from obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2006; 290: R154-R161.
14. HIROKI J, SHIMOKAWA H, HIGASHI M, MORIKAWA K, KANDABASHI T, KAWAMURA N, KUBOTA T, ICHIKI T, AMANO M, KAIBUCHI K, TAKESHITA A. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. J Mol Cell Cardiol 2004; 37: 537-546.
15. SORDELLA R, JIANG W, CHEN GC, CURTO M, SETTLEMAN J. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 2003; 113: 147-158.
16. FALL T, INGELSSON E. Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol 2014; 382: 740-757.
17. GUO X, CHENG S, TAYLOR KD, CUI J, HUGHES R, QUIÑONES MJ, BULNES-ENRIQUEZ I, DE-LA-ROSA R, AUREA G, YANG H, HSUEH W, ROTTER JI. Hypertension genes are genetic markers for insulin sensitivity and resistance. Hypertension 2005; 45: 799-803.
18. TABUR S, OZTUZCU S, DUZEN IV, ERAYDIN A, EROGLU S, OZKAYA M, DEMIRYÜREK AT. Role of the transient receptor potential (TRP) channel gene expressions and TRP melastatin (TRPM) channel gene polymorphisms in obesity-related metabolic syndrome. Eur Rev Med Pharmacol Sci 2015 (in press).
19. GÜNDOGDU MS, LIU H, METZDORF D, HILDEBRAND D, AIGNER M, AKTORIES K, HEEG K, KUBATZKY KF. The haematopoietic GTPase RhoH modulates IL3 signalling through regulation of STAT activity and IL3 receptor expression. Mol Cancer 2010; 9: 225.
20. LI X, BU X, LU B, AVRAHAM H, FLAVELL RA, LIM B. The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function. Mol Cell Biol 2002; 22: 1158-1171.
21. SADOK A, MARSHALL CJ. Rho GTPases: masters of cell migration. Small GTPases 2014; 5: e29710.
22. DARYADEL A, YOUSEFI S, TROI D, SCHMID I, SCHMIDTMENDE J, MORDASINI C, DAHINDEN CA, ZIEMIECKI A, SIMON HU. RhoH/TTF negatively regulates leukotriene production in neutrophils. J Immunol 2009; 182: 6527-6532.
23. WHEELER AP, RIDLEY AJ. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 2004; 301: 43-49.
24. ASPENSTRÖM P, FRANSSON A, SARAS J. Rho GTPases have diverse effects on the organization of the actin filament system. Biochem J 2004; 377: 327-337.
25. WENNERBERG K, FORGET MA, ELLERBROEK SM, ARTHUR WT, BURRIDGE K, SETTLEMAN J, DER CJ, HANSEN SH. Rnd proteins function as RhoA antagonists by activating p190 RhoGAP. Curr Biol 2003; 13: 1106-1115.
26. WARTON K, FOSTER NC, GOLD WA, STANLEY KK. A novel gene family induced by acute inflammation in endothelial cells. Gene 2004; 342: 85-95.
27. NOFER JR, FEUERBORN R, LEVKAU B, SOKOLL A, SEEDORF U, ASSMANN G. Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux. J Biol Chem 2003; 278: 53055-53062.
28. LOIRAND G, SAUZEAU V, PACAUD P. Small G proteins in the cardiovascular system: physiological and pathological aspects. Physiol Rev 2013; 93: 1659- 1720.
29. USUI I, IMAMURA T, HUANG J, SATOH H, OLEFSKY JM. Cdc42 is a Rho GTPase family member that can mediate insulin signaling to glucose transport in 3T3-L1 adipocytes. J Biol Chem 2003; 278: 13765-13774.
30. MILAGRO FI, CAMPIÓN J, MARTÍNEZ JA. Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity (Silver Spring) 2006; 14: 1118-1123.
31. KANDA T, WAKINO S, HOMMA K, YOSHIOKA K, TATEMATSU S, HASEGAWA K, TAKAMATSU I, SUGANO N, HAYASHI K, SARUTA T. Rho-kinase as a molecular target for insulin resistance and hypertension. FASEB J 2006; 20: 169-171.
32. SCHINZARI F, TESAURO M, ROVELLA V, DI-DANIELE N, GENTILESCHI P, MORES N, CAMPIA U, CARDILLO C. Rhokinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome. Am J Physiol Endocrinol Metab 2012; 303: E806-E811.
33. FUJITA K, NISHIZAWA H, FUNAHASHI T, SHIMOMURA I, SHIMABUKURO M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006; 70: 1437-1442.
34. VINCENT HK, TAYLOR AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 2006; 30: 400-418.
35. JIN L, YING Z, WEBB RC. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol 2004; 287: H1495-H1500.
36. SEASHOLTZ TM, WESSEL J, RAO F, RANA BK, KHANDRIKA S, KENNEDY BP, LILLIE EO, ZIEGLER MG, SMITH DW, SCHORK NJ, BROWN JH, O'CONNOR DT. Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity. Hypertension 2006; 47: 937-947.
37. ZHAO Q, WANG L, YANG W, CHEN S, HUANG J, FAN Z, LI H, LU X, GU D. Interactions among genetic variants from contractile pathway of vascular smooth muscle cell in essential hypertension susceptibility of Chinese Han population. Pharmacogenet Genomics 2008; 18: 459-466.
38. DEMIRYUREK AT, ERBAGCI I, OZTUZCU S, ALASEHIRLI B, OZKARA E, SEKER M, SÖNMEZ A, OZSAN M, CAMCI C. Lack of association between the Thr431Asn and Arg83Lys polymorphisms of the ROCK2 gene and diabetic retinopathy. Curr Eye Res 2010; 35: 1128-1134.
39. YOSHIDA T, KATO K, YOKOI K, OGURI M, WATANABE S, METOKI N, YOSHIDA H, SATOH K, AOYAGI Y, NISHIGAKI Y, NOZAWA Y, YAMADA Y. Association of genetic variants with chronic kidney disease in individuals with different lipid profiles. Int J Mol Med 2009; 24: 233-246.